Adverse Event Reporting to IRBs — Improving Human Subject Protection: Guidance for Clinical Investigators, Sponsors, and IRBs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 14, 2009
May 6, 2020
8b4e7049-16fc-40f8-b121-81ece765bc26
Related Documents
Financial Disclosure by Clinical Investigators: Guidance for Clinical Investigators, Industry,and FDA Staff
Guidance DocumentFebruary 1, 2013Office of the Commissioner
Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims: Guidance for Industry
Guidance DocumentDecember 9, 2009Center for Drug Evaluation and Research
Electronic Source Data in Clinical Investigations: Guidance for Industry
Guidance DocumentSeptember 18, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.